Jump to content

Gordon Binder

From Wikipedia, the free encyclopedia
(Redirected from Gordon M. Binder)
Gordon M. Binder
Born1935
NationalityAmerican
EducationPurdue University (B.S.E.E)
Harvard Business School (M.B.A)
Occupations
  • Businessman
  • investor
  • scientist

Gordon M. Binder (born 1935) is an American businessman.[1][2][3]

Early life and education

[edit]

Gordon Binder was born in Missouri.[2] He graduated from Purdue University with a Bachelor of Science in Electrical Engineering and received an M.B.A. from the Harvard Business School as a Baker Scholar.[1][2]

Career

[edit]

Binder worked in managing position at Litton Industries and the Ford Motor Company.[1][3] He served as Chief Financial Officer at the System Development Corporation.[1][3] In 1982, he joined Amgen as CFO.[1] From 1988 to 2000, he served as its CEO.[1][3][4]

He is the Founder and Managing Director of Coastview Capital, a private investment firm.[1][3][5] He also serves as Chairman of SRU Biosystems.[6] He sits on the Boards of Directors of Acadia Pharmaceuticals, Cellular Genomics, PhRMA and the Biotechnology Industry Organization.[1][3] along with Henri Termeer.[7]

He is a member of the Board of Trustees of the Massachusetts Institute of Technology, the California Institute of Technology and the American Enterprise Institute.[1][3][8][9] He was elected a Fellow of the American Academy of Arts and Sciences in 2001.[10]

Bibliography

[edit]
  • Science lessons: What the Business of Biotech Taught Me About Management (with Philip Bashe, Harvard Business Review Press, 2008)

References

[edit]
  1. ^ a b c d e f g h i "Gordon M. Binder", Bloomberg Business Week, nd, archived from the original on June 5, 2013
  2. ^ a b c Harvard Business School
  3. ^ a b c d e f g "Biography", Milken Institute, nd, archived from the original on 2013-06-19
  4. ^ Lawrence M. Fisher, BUSINESS PEOPLE; Amgen Officer Shifts Surprise to Analysts, The New York Times, October 27, 1988
  5. ^ Bloomerg BusinessWeek: Coastview Capital
  6. ^ A Sharper Nose for Danger, Bloomberg BusinessWeek, May 24, 2004
  7. ^ Terrapinn Holdings Ltd (2015). Mr Henri Termeer: Chief Executive Officer, Former Genzyme. Orphan Drug Congress. Retrieved 27 September 2015.
  8. ^ The MIT Corporation
  9. ^ American Enterprise Institute Board of Trustees
  10. ^ "Book of Members, 1780–2010: Chapter B" (PDF). American Academy of Arts and Sciences. Retrieved July 20, 2011.